Stock Price Quote

JHS SVENDGAARD LABORATORIES LTD.

NSE : JHSBSE : 532771ISIN CODE : INE544H01014Industry : Household & Personal ProductsHouse : Private
BSE18.090.34 (+1.92 %)
PREV CLOSE ( ) 17.75
OPEN PRICE ( ) 18.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11972
TODAY'S LOW / HIGH ( )18.09 18.10
52 WK LOW / HIGH ( )15 39.45
NSE18.000.2 (+1.12 %)
PREV CLOSE( ) 17.80
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29785
TODAY'S LOW / HIGH( ) 17.85 18.00
52 WK LOW / HIGH ( )15.55 39.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2004
Management Info
Rajagopal Chakravarthi Venkateish - Chairman Nikhil Nanda - Managing Director
Registered Office

Address Trilokpur Road,Kheri (Kala- Amb),Tehsil- Nahan,
Sirmour Dist,
Himachal Pradesh-173030

Phone 9218400346

Email enquiry@svendgaard.com

Website www.svendgaard.com

Registrars Details
Alankit Assignments Ltd.
3 E,7, Jhandewalan Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

22Apr JHS Svendgaard Laboratories informs ab
JHS Svendgaard Laboratories has informed that it enclosed Compliance Cer..
05Mar Jhs Svendgaard Laboratories informs ab
Jhs Svendgaard Laboratories has informed regarding the withdrawal of Sch..
17Feb JHS Svendgaard Laboratories informs ab
JHS Svendgaard Laboratories has informed that the exchange has received..
31Jan JHS Svendgaard Laboratories informs ab
JHS Svendgaard Laboratories has informed that it enclosed the disclosure..
11Jan Jhs Svendgaard Laboratories informs ab
Jhs Svendgaard Laboratories has informed that the Company has submitted..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit0.139999999999984-151.43
Gross Profit 5.50999999999998 -197.21
Operating Profit 22.8351.34
Net Sales 143819.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Colgate Palmol. (I) (BSE)
peergroup  2855.25 (2.16%)
M.Cap ( in Cr)77913.00
Gillette India (BSE)
peergroup  6256.15 (0.84%)
M.Cap ( in Cr)20357.94
AARTISURF (BSE)
peergroup  657.05 (3.96%)
M.Cap ( in Cr)575.57
Inflame Appliances (BSE)
peergroup  499.20 (4.87%)
M.Cap ( in Cr)366.87
Emami (BSE)
peergroup  480.10 (3.55%)
M.Cap ( in Cr)20956.37

Shareholding Pattern

NON-INSTITUTION 53.76%
PROMOTERS 37.73%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About JHS Svendgaard Laboratories Ltd.

JHS Svendgaard Laboratories Ltd. was incorporated in the year 2004. Its today's share price is 18.09. Its current market capitalisation stands at Rs 141.82 Cr. In the latest quarter, company has reported Gross Sales of Rs. 819.16 Cr and Total Income of Rs.949.79 Cr. The company's management includes Upma Chawdhry, Komal Jha, Vinay Mittal, Rohina Sanjay Sangtani, Mukul Pathak, Kapil Minocha, Nikhil Nanda, Rajagopal Chakravarthi Venkateish.

It is listed on the BSE with a BSE Code of 532771 , NSE with an NSE Symbol of JHS and ISIN of INE544H01014. It's Registered office is at Trilokpur Road,Kheri (Kala- Amb),Tehsil- NahanSirmour Dist-173030, Himachal Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Haribhakti & Co, SN Dhawan & Co, SN Dhawan & Co LLP, Tattvam & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.